|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,847.25 DKK | -5.44% |
|
-1.51% | -8.58% |
| 02:09pm | Genmab: 2025 miss and cautious 2026 targets erode investor confidence |  |
| 09:29am | DNB Carnegie Raises Target Price for Genmab to 2,300 Danish Kroner (from 2,235), Reiterates Buy Recommendation | FW |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -5.12% | -1.51% | -8.58% | +20.32% | -25.91% | 19.05B |  |  | |
- Stock Market
- Equities
- GMAB Stock
- Charts Genmab A/S
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition